STRAINS
Choose by chemistry and dose, not by the indica/sativa label. If strain names are unreliable, how do you choose? The honest answer is to read the chemotype, the cannabinoid ratio and the dominant terpenes, and to respect dose, because the same plant can feel different at different amounts.
Start with the cannabinoid ratio
The THC:CBD balance sets the baseline. High-THC, low-CBD tends to be more intoxicating; balanced or CBD-forward profiles are gentler and less likely to cause anxiety. This matters more than any strain name.
Then read the terpenes
Dominant terpenes shape the character. As a rough guide: myrcene-heavy profiles lean relaxing, limonene-heavy lean bright and uplifting, pinene is associated with alertness, and linalool with calm. These are tendencies, not rules.
This is where aroma becomes useful: what a plant smells like hints at its terpene profile.
Respect the dose
THC is biphasic: a low dose can relax while a high dose does the opposite. Choosing “the right strain” and then overshooting the dose undoes the choice. Start low, especially with edibles.
A practical order
Continue exploring
Chemovar Pharmacology, Biphasic THC Dosing, and Terpene Modulation
Selecting cannabis by expected subjective effect requires reading the full cannabinoid-to-terpene ratio (chemovar) and controlling total milligram intake rather than relying on Indica or Sativa labels. In a landmark pharmacological review, Russo (2011, British Journal of Pharmacology, PMID 21749363) documented how phytocannabinoids and terpenoids such as d-limonene, beta-myrcene, linalool, alpha-pinene, and beta-caryophyllene interact across neurotransmitter and receptor targets. However, controlled receptor-signaling assays by Santiago et al. (2019, Cannabis and Cannabinoid Research, PMID 32116073) demonstrated that common cannabis terpenes do not directly activate or allosterically modulate human CB1 or CB2 receptors via potassium-channel signaling, indicating that terpenoid effects operate through independent neurochemical pathways alongside biphasic delta-9-THC dose responses.
Frequently Asked Questions
Why is cannabinoid and terpene ratio more reliable than Indica or Sativa labels when choosing by effect?
Indica and Sativa originally described plant morphology rather than chemical output. The ratio of delta-9-THC to CBD and the dominant terpene profile (chemovar) provide a measurable basis for comparing batches (Russo, 2011, PMID 21749363).
Do cannabis terpenes bind directly to CB1 receptors to change the high?
Controlled in vitro assays show that major cannabis monoterpenes and sesquiterpenes (except beta-caryophyllene at CB2) do not directly activate or modulate CB1 receptor signaling, meaning their behavioral effects arise through separate neural targets (Santiago et al., 2019, PMID 32116073).
Why can the same strain feel relaxing at a low dose and anxious at a high dose?
Delta-9-THC exhibits a biphasic dose-response curve: low milligram doses often feel mild, whereas higher doses can trigger tachycardia and acute anxiety regardless of the cultivar name.